Jose Herrera

IVC Balloonmatic LIC, Venezuela

Title: Percutaneous Transluminal Caval-flow Regulation PTCR®: An Emerging Innovation to Reduce Total Cardiac Burden in Heart Failure Patients. A Change of Paradigm in the Horizon.

Biography

Jose E. Herrera was born in Porlamar Venezuela on October 20, 1953.Physician graduated from the University of the Andes, Mérida state, Venezuela. in 1977. Approval of the ECFMG USA exam (revalidation of medical degree) March 1979, Postgraduate in Cardiology (Doctor's Degree) at Jose Ignacio Baldo Hospital (Caracas-Venezuela) and in the University Hospital of Caracas, 1979-1980. Advanced Echocardiography Course at Thomas Jefferson University Hospital, Philadelphia, United States, 1984. He was a faculty at the meetings of the different TCT congresses 2016, 2015, 2016, USA, ICI Meeting held in Israel 2015, 2016, 2017, 2018, 2019, 2020, is recepient the cardiovascular innovation award at the ICI 2015 meeting. He currently has 9 patents for medical device and PTCR procedure USA, Russia, Europe, Geneva and Japan. Scientific article published in the journal ESC Heart Failure 2022. He is a reviewer of the ESC Heart Failure and ACC Journal.

Abstract

Abstract:

Background: Preload reduction in heart failure has been achieved with high potency diuretics. However, no study has been conducted in humans to assess the effect of inferior vena cava intermittent occlusion for preload reduction. This study aims to investigate the acute haemodynamic effects and echo data of percutaneous transluminal flow regulation (PTCR®) with an inferior vena cava regulator balloon in heart failure patients. This observational study is to demonstrate that the regulation of the caval flow, the reduction of the total cardiac load produces reversal of the remodeling of and thus offers a new alternative emerging therapy to treat Heart Failure Patients.

Methods: Six patients were included in the study: four men (55 ± 6 years old) and two women (63 ± 4 years old). Baseline evaluations included Doppler echocardiogram, coronary angiogram, and right heart catheterization. Caval balloon was kept inflated for 30 min, and right catheterization and control echocardiogram were performed while the balloon was still inflated. The balloon was then deflated and removed. Right haemodynamic variables were evaluated before balloon insertion and with the inflated balloon.

Conclusion: The haemo dynamic and echocardiographic changes obtained in our study using PTCR® suggest that this innovative approach can play a beneficial role in the heart failure treatment.